Following the advice of a review committee set up by the AYUSH ministry, the State Licensing Authority of Uttarakhand has given a licence for Coronil tablet to be used as a supporting measure in the management of COVID-19 without claiming cure, the Lok Sabha was informed on Friday.
Minister of
State for Health Bharati Pravin Pawar, in a written reply, said the Interdisciplinary Technical Review Committee (ITRC) setup by the AYUSH ministry reviewed the application submitted by the Patanjali Research Foundation Trust for updating the AYUSH license for Divya Coronil tablet from immunity booster’ to medicine for COVID-19′.
The committee suggested that the tablet may be used as supporting measure in Covid management, she said.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…